# DRTS (Alpha Tau Medical Ltd.) - SEC EDGAR Financial Statements

> Alpha Tau Medical Ltd. reported $105.7M in total assets and a net loss of $42.63M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/DRTS
- Markdown: https://convexityos.com/fundamentals/DRTS.md
- SEC CIK: 0001871321
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 20, 2026, 05:28 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001871321&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$42.29M | Operating profit |
| Net Income | FY 2025 | -$42.63M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.53 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$32.76M | Operating CF less CapEx |
| Cash & ST Investments | Dec 31, 2025 | $73.13M | Total debt: $7.37M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $32.06M | $27.02M | $26.42M | $20.89M | $11.45M | $7.54M | $6.64M |
| **Operating Income** | -$42.29M | -$36.04M | -$35.68M | -$32.14M | -$13.79M | -$9.24M | $8.01M |
| **EBITDA** | -$41.06M | -$34.94M | -$34.61M | -$31.16M | -$13.01M | -$9.16M | $8.08M |
| Interest Expense | $347K | $303K | $75K | -- | -- | -- | -- |
| Income Before Tax | -$42.51M | -$31.74M | -$29.14M | -$33.74M | -$27.26M | -$8.72M | $8.32M |
| Income Tax Expense | $121K | $6.0K | $16K | $20K | $7.0K | $158K | -$146K |
| **Net Income** | -$42.63M | -$31.75M | -$29.16M | -$33.76M | -$27.27M | -$8.88M | -$8.37M |
| Basic EPS | -$0.53 | -$0.45 | -$0.42 | -$0.53 | -$0.67 | -$0.22 | -$0.25 |
| **Diluted EPS** | -$0.53 | -$0.45 | -$0.42 | -$0.53 | -$0.67 | -$0.22 | -$0.25 |
| Basic Shares Outstanding | 80.6M | 69.9M | 69.4M | 63.5M | 40.5M | 40.3M | 33.8M |
| Diluted Shares Outstanding | 80.6M | 69.9M | 69.4M | 63.5M | 40.5M | 40.3M | 33.8M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $12.20M | $13.72M | $12.66M | $5.84M | $23.24M | $15.60M |
| Short-Term Investments | $60.92M | $45.88M | $69.13M | $98.69M | $8.08M | -- |
| **Cash & Short-Term Investments** | $76.90M | $62.85M | $84.94M | $104.5M | $31.32M | $15.60M |
| **Total Current Assets** | $78.30M | $64.23M | $85.76M | $106.5M | $32.64M | $47.45M |
| Property, Plant & Equipment, Net | $19.66M | $13.93M | $12.80M | $7.47M | $7.55M | $5.39M |
| **Total Non-Current Assets** | $27.35M | $21.98M | $21.63M | $13.67M | $9.57M | $5.53M |
| **Total Assets** | $105.7M | $86.20M | $107.4M | $120.1M | $42.22M | $52.99M |
| Accounts Payable | $3.87M | $3.53M | $2.57M | $1.42M | $1.20M | $964K |
| Other Current Liabilities | -- | -- | -- | -- | $3.20M | $1.12M |
| **Total Current Liabilities** | $10.51M | $8.68M | $7.10M | $4.34M | $4.41M | $2.09M |
| **Total Non-Current Liabilities** | $18.05M | $14.86M | $15.81M | $10.15M | $18.62M | $5.37M |
| **Total Liabilities** | $28.55M | $23.54M | $22.91M | $14.49M | $23.03M | $7.45M |
| **Total Debt (incl. Leases)** | $7.37M | $6.97M | $7.67M | $5.19M | -- | -- |
| Retained Earnings | -$190.1M | -$147.5M | -$115.8M | -$86.60M | -$52.84M | -$25.57M |
| **Total Stockholders' Equity** | $77.10M | $62.67M | $84.47M | $105.7M | -$34.78M | -$8.43M |
| Total Equity | $77.10M | $62.67M | $84.47M | $105.7M | -$34.78M | -$8.43M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $12.20M | $13.72M | $12.66M | $5.84M | $23.24M | $15.60M |
| Short-Term Investments | $60.92M | $45.88M | $69.13M | $98.69M | $8.08M | -- |
| **Cash & Short-Term Investments** | $76.90M | $62.85M | $84.94M | $104.5M | $31.32M | $15.60M |
| **Total Current Assets** | $78.30M | $64.23M | $85.76M | $106.5M | $32.64M | $47.45M |
| Property, Plant & Equipment, Net | $19.66M | $13.93M | $12.80M | $7.47M | $7.55M | $5.39M |
| **Total Non-Current Assets** | $27.35M | $21.98M | $21.63M | $13.67M | $9.57M | $5.53M |
| **Total Assets** | $105.7M | $86.20M | $107.4M | $120.1M | $42.22M | $52.99M |
| Accounts Payable | $3.87M | $3.53M | $2.57M | $1.42M | $1.20M | $964K |
| Other Current Liabilities | -- | -- | -- | -- | $3.20M | $1.12M |
| **Total Current Liabilities** | $10.51M | $8.68M | $7.10M | $4.34M | $4.41M | $2.09M |
| **Total Non-Current Liabilities** | $18.05M | $14.86M | $15.81M | $10.15M | $18.62M | $5.37M |
| **Total Liabilities** | $28.55M | $23.54M | $22.91M | $14.49M | $23.03M | $7.45M |
| **Total Debt (incl. Leases)** | $7.37M | $6.97M | $7.67M | $5.19M | -- | -- |
| Retained Earnings | -$190.1M | -$147.5M | -$115.8M | -$86.60M | -$52.84M | -$25.57M |
| **Total Stockholders' Equity** | $77.10M | $62.67M | $84.47M | $105.7M | -$34.78M | -$8.43M |
| Total Equity | $77.10M | $62.67M | $84.47M | $105.7M | -$34.78M | -$8.43M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$42.63M | -$31.75M | -$29.16M | -$33.76M | $27.27M | $8.88M | $8.46M |
| Depreciation & Amortization | $1.23M | $1.10M | $1.07M | $979K | $776K | $86K | $66K |
| Stock-Based Compensation | $10.62M | $9.92M | $7.93M | $6.75M | $812K | $596K | $546K |
| Change in Payables | $337K | $965K | $1.14M | $220K | $239K | $114K | $148K |
| **Operating Cash Flow** | -$26.68M | -$19.78M | -$17.96M | -$23.88M | -$11.81M | -$7.25M | -$6.91M |
| Capital Expenditure | -$6.08M | -$2.24M | -$6.40M | -$904K | -$2.93M | -$3.77M | -$1.29M |
| **Free Cash Flow** | -$32.76M | -$22.02M | -$24.36M | -$24.78M | -$14.74M | -$11.02M | -$8.20M |
| **Investing Cash Flow** | -$20.59M | $20.77M | $18.68M | -$89.94M | $19.27M | -$7.82M | -$10.16M |
| Common Stock Issued | $45.50M | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $45.77M | $25K | $5.30M | $96.91M | $111K | $29.32M | $5.32M |
| **Net Change in Cash** | -$1.52M | $1.07M | $5.97M | -$17.17M | $7.68M | $14.33M | -$11.77M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -55.3% | -50.7% | -34.5% | -32.0% | -- | -- | -- |
| Return on Assets (ROA) | -40.3% | -36.8% | -27.2% | -28.1% | -64.6% | -16.8% | -- |
| Current Ratio | 7.45x | 7.40x | 12.07x | 24.55x | 7.41x | 22.73x | -- |
| Quick Ratio | 7.32x | 7.25x | 11.96x | 24.10x | 7.11x | 7.47x | -- |
| Debt to Equity | 0.10x | 0.11x | 0.09x | 0.05x | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -215.4% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
